SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending after its BYSANTI drug received FDA approval for bipolar I disorder and schizophrenia, with the community anticipating a significant re-rating, potential for a short squeeze, and long-term buyout prospects due to the drug's blockbuster market potential and patent protection.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

Crowdstrike is trending as Anthropic's new Claude Code Security tool has sparked a sell-off across cybersecurity stocks, triggering community debate on whether the AI-powered code scanning truly impacts CRWD's core endpoint and runtime protection business or is an overblown reaction amidst broader software valuation concerns.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

The Roundhill Magnificent Seven ETF ($MAGS) is a major talking point as investors debate the sustainability of the AI-driven mega-cap rally, particularly following recent disappointments from major tech results and concerns about the group's leadership. Community sentiment is mixed, focusing on crucial technical support levels and the potential for a broader market rotation away from these dominant names.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadog is actively discussed after a strong Q4 earnings beat and optimistic Q1 revenue guidance, highlighting accelerated AI-driven demand and robust platform integrations. This performance is fueling a bullish rebound for the stock, with many seeing it as a critical AI infrastructure play, though some still cite premium valuation and sector-wide AI disruption fears as headwinds.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESHA is trending as a low-float SPAC, generating significant community discussion around its potential for a short squeeze amidst volume spikes and trading halts. Speculation is high regarding a substantial price surge, especially given its impending business combination deadline.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Kennedy Space Center, FL.

Starfighters Space Inc

Starfighters Space (FJET) is driving significant investor conversation and high volatility as its team rings the NYSE Opening Bell, following successful wind tunnel testing for its STARLAUNCH I rocket. The community is intensely debating its potential for a short squeeze and its role in the expanding space and defense sectors ahead of next week's NYSE Space Summit, with many anticipating further upward movement.

BlackRock Institutional Trust Company N.A. - iShares Expanded Tech-Software Sector ETF

iShares Expanded Tech-Software Sector ETF

The iShares Expanded Tech-Software Sector ETF ($IGV) is seeing a deep sell-off, driven by escalating fears that Anthropic's Claude AI model poses a significant threat to traditional enterprise and cybersecurity software, although many in the community contend the market is overreacting to a 'fake narrative' while the sector experiences extreme oversold conditions.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The VanEck Semiconductor ETF (SMH) is trending due to robust demand for AI infrastructure and surging memory chip prices, which are propelling its major holdings like TSM and MU. While many investors see it as a strong play, others in the community view its rapid, 'parabolic' ascent as an 'AI bubble' poised for correction amidst overvaluation concerns.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as community discussion focuses on its strategic exclusion from China's national drug list, aiming to preserve pricing power, while investors keenly await a pending U.S. Supreme Court decision on its patent infringement case. This coincides with anticipated positive financial results and ongoing speculation about a potential acquisition as the company positions for a turnaround.

Featured in Matt Furies latest book Cortex Vortex as Ratos nemesis. The character is also part of ZOGZ which confirms its real name.  Matt Furie, the artist best known for creating Pepe the Frog, has been working on a new book. The news comes from his editor, who goes by the handle @beuys_on_sale_ on Instagram. In a recent post, the editor hinted at an upcoming project featuring new characters named Gasspas and Rato. Gasspas’s visual appearance can be inferred from the artwork. In one illustration, Gasspas is depicted looming over two rats (Rato and Wat), gazing down at them in a menacing way (an image that has circulated among collectors). This inferred that Gasspas is Ratos nemesis in the new book Cortex Vortex reinforced by community quips that “cats eat rats”. Gasspas debuted as part of ZOGZ, a collection of 111 original NFT character illustrations by Matt Furie launched in May 2023.

Gasspas

Gasspas (GASS) is trending amidst recent price fluctuations and enthusiastic community discussion, with many drawing parallels to the success of other meme coins like PEPE and hoping for significant gains. While proponents are rallying for a "HODL" strategy and a "community takeover" to "drop a zero," a counter-narrative exists, labeling it as a "pump and dump" or "dead coin" as it navigates the volatile meme coin market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Universal Health Q4 Earnings: Will Acute Care Offset Rising Costs?

UHS heads into Q4 earnings with strong Acute Care and Behavioral growth, but rising labor and supply costs could cloud a potential beat.

Unlocking Q4 Potential of Universal Health Services (UHS): Exploring Wall Street Estimates for Key Metrics

Get a deeper insight into the potential performance of Universal Health Services (UHS) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Skandinaviska Enskilda Banken AB publ Lowers Position in Universal Health Services, Inc. $UHS

Skandinaviska Enskilda Banken AB publ cut its position in shares of Universal Health Services, Inc. (NYSE:UHS - Free Report) by 45.7% during the 3rd quarter, according to its most recent disclosure...

Here's Why Universal Health Services (UHS) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Pzena Investment Management LLC Grows Stock Holdings in Universal Health Services, Inc. $UHS

Pzena Investment Management LLC raised its holdings in shares of Universal Health Services, Inc. (NYSE:UHS - Free Report) by 310.2% in the 3rd quarter, according to its most recent Form 13F filing...

Community Health Systems (CYH) Reports Break-Even Earnings for Q4

Community Health Systems (CYH) delivered earnings and revenue surprises of +100.00% and -1.18%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Universal Health Services (UHS) to Release Earnings on Wednesday

Universal Health Services (NYSE:UHS) will be releasing its Q4 2025 earnings after the market closes on Wednesday, February 25. (View Earnings Report at...

UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT MARCH HEALTHCARE CONFERENCES

UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT MARCH HEALTHCARE CONFERENCES UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT MARCH HEALTHCARE CONFERENCES PR Newswire KING OF PRUSSIA, Pa., Feb. 17, 2026...

Are Investors Undervaluing Universal Health Services (UHS) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Rhumbline Advisers Reduces Stake in Universal Health Services, Inc. $UHS

Rhumbline Advisers cut its stake in Universal Health Services, Inc. (NYSE:UHS - Free Report) by 5.8% in the 3rd quarter, according to its most recent filing with the Securities and Exchange...

Universal Health Services, Inc. engages in providing hospital and healthcare services. It operates through the following segments: Acute Care Hospital Services, Behavioral Health Care Services, and Other. The Acute Care Hospital Services segment includes hospitals, freestanding emergency departments, and ambulatory centers. The Behavioral Health Care Services segment offers treatment programs for depression, anxiety, psychotic diagnoses, bipolar disorder, post-traumatic stress disorder, and neurorehabilitation. The Other segment consists of centralized services such as information technology, purchasing, reimbursement, accounting and finance, taxation, legal, advertising, and design and construction. The company was founded by Alan B. Miller in 1979 and is headquartered in King of Prussia, PA.

UHS
Universal Health Services, Inc. - Ordinary Shares - Class B

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest UHS News

UHSUniversal Health Services, Inc. - Ordinary Shares - Class B